Wayne Paterson - 16 Dec 2024 Form 4 Insider Report for Anteris Technologies Global Corp. (AVR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Dec 2024, 21:19:34 UTC
Prior SEC filing
12 Dec 2024
Next SEC filing
21 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew McDonnell, Attorney-in-Fact

Key filing fact

Wayne Paterson filed Form 4 for Anteris Technologies Global Corp. (AVR) on 18 Dec 2024.

Key facts

  • This page summarizes Wayne Paterson's Form 4 filing for Anteris Technologies Global Corp. (AVR).
  • 9 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 18 Dec 2024, 21:19.

Change

  • Previous filing in this sequence was filed on 12 Dec 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVR transaction

Common Stock

Award

Transaction value
Shares
+20,334
Change %
Price
Shares after
20,334
Date
16 Dec 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+14,358
Change %
Price
$0.000000
Shares after
14,358
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,358
Exercise price
$23.56
Footnotes
F2, F3, F4
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+31,890
Change %
Price
$0.000000
Shares after
31,890
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,890
Exercise price
$3.76
Footnotes
F2, F3, F5
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+233,000
Change %
Price
$0.000000
Shares after
233,000
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
233,000
Exercise price
$7.13
Footnotes
F2, F3, F6
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+41,222
Change %
Price
$0.000000
Shares after
41,222
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
41,222
Exercise price
$6.04
Footnotes
F2, F3, F7
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+258,778
Change %
Price
$0.000000
Shares after
258,778
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
258,778
Exercise price
$8.25
Footnotes
F2, F3, F8
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+700,000
Change %
Price
$0.000000
Shares after
700,000
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
700,000
Exercise price
$15.28
Footnotes
F2, F3, F9
AVR transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+300,000
Change %
Price
$0.000000
Shares after
300,000
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$14.64
Footnotes
F2, F3, F10
AVR transaction Derivative

Option

Award

Transaction value
$0
Shares
+4,167
Change %
Price
$0.000000
Shares after
4,167
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,167
Exercise price
$18.46
Footnotes
F2, F3, F11, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Received in exchange for an equivalent number of ordinary shares of Anteris Technologies Ltd ("ATL") in connection with a series of reorganization transactions pursuant to which the Issuer received all of the issued and outstanding shares of ATL pursuant to a scheme of arrangement (the "Scheme") under Australian law between ATL and its shareholders under Part 5.1 of the Australian Corporations Act 2001 (Cth) (the "Corporations Act"). On December 16, 2024, the effective date of the Scheme and the closing of the Issuer's U.S. initial public offering (the "Effective Date"), the closing price of the Issuer's common stock was $5.50 per share.

Footnote F2

Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64.

Footnote F3

Legacy awards originally issued by ATL that were assumed by the Issuer pursuant to a scheme of arrangement between ATL and its optionholders under Part 5.1 of the Corporations Act, effective on the Effective Date.

Footnote F4

The option vested in three equal annual installments beginning on December 31, 2018.

Footnote F5

The option vested in three equal annual installments beginning on December 31, 2019.

Footnote F6

The option vested in two equal installments on February 8, 2022 and June 24, 2022.

Footnote F7

The option vests in three equal annual installments beginning on December 31, 2022, subject to the Reporting Person's continued service.

Footnote F8

The option vests in three equal annual installments beginning on December 31, 2022, subject to the Reporting Person's continued service.

Footnote F9

The option vests in three equal annual installments beginning on September 15, 2024, subject to the Reporting Person's continued service.

Footnote F10

The option vests in three equal annual installments beginning on June 19, 2025, subject to the Reporting Person's continued service.

Footnote F11

The non-incentive plan option is vested and may be exercised until May 31, 2025.

Footnote F12

The options were issued on May 31, 2023 as free-attaching options relating to a share placement which occurred on February 15, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .